← All organizations
Highest phase reached
Phase 3
Timeline
1990s
- Jun 1, 1997
Biothera— Founded
2020s
- May 22, 2025
ustekinumab— Marketing Organization
Drugs by trial phase (42 distinct, 66 trials)
Phase 3 (19 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Phase 1 (14 own, 0 via acquisition)
Indications
Studied for
- Arthritis
- Arthritis, Psoriatic
- Arthritis, Rheumatoid
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Colorectal Neoplasms
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Non-Hodgkin
- Macular Degeneration
- Melanoma
- Neoplasms
- Neuromyelitis Optica
- Pancreatic Neoplasms
- Psoriasis
- Spondylitis
- Spondylitis, Ankylosing
- Squamous Cell Carcinoma of Head and Neck
- Triple Negative Breast Neoplasms
Marketed drugs (1)
Recent trials (50)
- NCT07180862Lead sponsorPhase 1Sep 30, 2025
- NCT06545617Lead sponsorPhase 1/Phase 2Jan 31, 2025
- NCT06543303Lead sponsorPhase 2Nov 15, 2024
- NCT06543303OfficialPhase 2Nov 15, 2024
- NCT06280196Lead sponsorPhase 3Jul 19, 2024
- NCT06376136Lead sponsorPhase 1/Phase 2May 8, 2024
- NCT06341114Lead sponsorPhase 1/Phase 2Apr 12, 2024
- NCT06321068Lead sponsorPhase 2/Phase 3Apr 9, 2024
- NCT06139536Lead sponsorPhase 1Dec 31, 2023
- NCT06123884Lead sponsorPhase 2/Phase 3Nov 30, 2023
- NCT06094179Lead sponsorPhase 1/Phase 2Nov 9, 2023
- NCT06111196Lead sponsorPhase 1Oct 31, 2023
- NCT05968508Lead sponsorPhase 1Aug 29, 2023
- NCT06044350Lead sponsorPhase 2Aug 1, 2023
- NCT05865574Lead sponsorPhase 1Jun 30, 2023
Details
- Founded
- Eagan, MN, US Jun 1, 1997
- Last known activity
- Sep 30, 2025